Ameriprise Financial Inc Viking Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

$375 Billion
Q4 2024

A detailed history of Ameriprise Financial Inc transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 1,479,596 shares of VKTX stock, worth $50.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,479,596

Previous 450,471 228.46%

Holding current value

$50.4 Million

Previous $28.5 Million 108.77%

% of portfolio

0.02%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$38.28 - $78.03 $39.4 Million - $80.3 Million	1,029,125 Added 228.46%	1,479,596 $59.5 Million
Q3 2024 Nov 14, 2024	BUY	$49.84 - $70.47 $8.39 Million - $11.9 Million	168,338 Added 59.67%	450,471 $28.5 Million
Q2 2024 Aug 14, 2024	SELL	$47.39 - $80.2 $7.97 Million - $13.5 Million	-168,281 Reduced 37.36%	282,133 $15 Million
Q1 2024 May 15, 2024	BUY	$17.4 - $94.5 $6.5 Million - $35.3 Million	373,373 Added 484.64%	450,414 $36.9 Million
Q4 2023 Feb 14, 2024	BUY	$9.24 - $19.64 $711,858 - $1.51 Million	77,041 New	77,041 $1.43 Million
Q1 2022 May 16, 2022	SELL	$3.0 - $4.88 $316,392 - $514,664	-105,464 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.6 - $6.72 $485,134 - $708,718	105,464 New	105,464 $485,000
Q3 2020 Nov 16, 2020	SELL	$5.73 - $8.11 $274,885 - $389,061	-47,973 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$4.35 - $8.08 $151,310 - $281,054	-34,784 Reduced 42.03%	47,973 $346,000
Q1 2020 May 15, 2020	BUY	$3.45 - $7.95 $106,691 - $245,853	30,925 Added 59.66%	82,757 $387,000
Q4 2019 Feb 14, 2020	BUY	$6.38 - $8.73 $153,968 - $210,681	24,133 Added 87.13%	51,832 $416,000
Q3 2019 Nov 14, 2019	BUY	$6.55 - $8.6 $32,520 - $42,699	4,965 Added 21.84%	27,699 $191,000
Q2 2019 Aug 14, 2019	BUY	$7.67 - $10.63 $66,391 - $92,013	8,656 Added 61.49%	22,734 $189,000
Q1 2019 May 15, 2019	SELL	$7.58 - $9.94 $600,730 - $787,764	-79,252 Reduced 84.92%	14,078 $140,000
Q4 2018 Feb 14, 2019	BUY	$7.16 - $16.21 $82,755 - $187,355	11,558 Added 14.13%	93,330 $714,000
Q3 2018 Nov 14, 2018	SELL	$9.7 - $19.65 $497,532 - $1.01 Million	-51,292 Reduced 38.55%	81,772 $1.42 Million
Q2 2018 Aug 14, 2018	BUY	$3.88 - $12.74 $516,288 - $1.7 Million	133,064 New	133,064 $1.25 Million

Others Institutions Holding VKTX

# of Institutions

466

Shares Held

65.8M

Call Options Held

5.84M

Put Options Held

3.76M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $2.61B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Viking Therapeutics, Inc. Transaction History